Sort by:
2023
January
FDA Grants Accelerated Approval For Alzheimer’s ...
Launched in 2009, the rationale for the RMS® Longevity Risk Model was to bring state-of-the-art developments in the science of aging to the…
2022
July
Looking at Long COVID
A sizeable proportion of people who recover from COVID-19 may then go on to experience some lingering symptoms. The most common of these are…
Subscribe to Our Newsletter
